Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Sales | 77,133 | 80,968 | 38,815 | 22,829 | 19,784 |
| Cost of Goods | 22,209 | 20,135 | 1,137 | N/A | N/A |
| Gross Profit | 54,924 | 60,833 | 37,678 | 22,829 | 19,784 |
| Operating Expenses | 97,975 | 63,487 | 122,481 | 38,823 | 34,990 |
| Operating Income | -42,842 | -2,519 | -84,666 | -15,994 | -15,206 |
| Interest Expense | 2,671 | 2,709 | 2,142 | 1,099 | 1,193 |
| Other Income | 2,027 | 1,873 | 2,935 | 2,523 | 2,822 |
| Pre-tax Income | -43,486 | -3,355 | -83,873 | -14,570 | -13,577 |
| Income Tax | 1,680 | 65 | 22 | 12 | 12 |
| Net Income Continuous | -45,166 | -3,420 | -83,895 | -14,582 | -13,589 |
| Net Income | $-45,166 | $-3,420 | $-83,895 | $-14,582 | $-13,589 |
| EPS Basic Total Ops | -0.43 | -0.03 | -0.87 | -0.16 | -0.14 |
| EPS Basic Continuous Ops | -0.43 | -0.03 | -0.87 | -0.15 | -0.14 |
| EPS Diluted Total Ops | -0.43 | -0.03 | -0.87 | -0.16 | -0.14 |
| EPS Diluted Continuous Ops | -0.43 | -0.03 | -0.87 | -0.15 | -0.14 |
| EBITDA(a) | $-25,854 | $14,436 | $-79,269 | $-12,283 | $-11,158 |